Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D HARWOOD

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Pharmaceutics|October 26, 2024
Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK FrameworkAneesh V Karkhanis, Matthew D Harwood, Felix Stader, et al.
AJNR. American Journal of Neuroradiology|January 1, 1996
Choroid plexus size in young children with Sturge-Weber syndromeP D Griffiths, S Blaser, M B Boodram, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2014
Lost in centrifugation: accounting for transporter protein losses in quantitative targeted absolute proteomicsMatthew D Harwood, Matthew R Russell, Sibylle Neuhoff, et al.
Environmental Toxicology and Chemistry|July 7, 2012
Use of solid phase microextraction to estimate toxicity: relating fiber concentrations to toxicity--part IYuping Ding, Peter F Landrum, Jing You, et al.
Ecology Letters|August 5, 2011
Combining α - and β -diversity models to fill gaps in our knowledge of biodiversityKarel Mokany, Thomas D Harwood, Jacob McC Overton, et al.
Biopharmaceutics & Drug Disposition|August 29, 2012
Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorptionM D Harwood, S Neuhoff, G L Carlson, et al.
Environmental Toxicology and Chemistry|July 13, 2012
Use of solid phase microextraction to estimate toxicity: relating fiber concentrations to body residues--part IIYuping Ding, Peter F Landrum, Jing You, et al.
Journal of Child Neurology|October 1, 1992
Magnetic resonance imaging evaluation of delayed myelination in Down syndrome: a case report and review of the literatureB K Koo, S Blaser, D Harwood-Nash, et al.
AJNR. American Journal of Neuroradiology|January 1, 1985
Radiologic characteristics of primitive neuroectodermal tumors in childrenN Altman, C R Fitz, S Chuang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2015
In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-Glycoprotein and Breast Cancer Resistance Protein: Part I: A Cross-Laboratory Comparison of Transporter-Protein Abundances and Relative Expression Factors in Human Intestine and Caco-2 CellsMatthew D Harwood, Brahim Achour, Sibylle Neuhoff, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Pharmaceutics|October 26, 2024
Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK FrameworkAneesh V Karkhanis, Matthew D Harwood, Felix Stader, et al.
AJNR. American Journal of Neuroradiology|January 1, 1996
Choroid plexus size in young children with Sturge-Weber syndromeP D Griffiths, S Blaser, M B Boodram, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2014
Lost in centrifugation: accounting for transporter protein losses in quantitative targeted absolute proteomicsMatthew D Harwood, Matthew R Russell, Sibylle Neuhoff, et al.
Environmental Toxicology and Chemistry|July 7, 2012
Use of solid phase microextraction to estimate toxicity: relating fiber concentrations to toxicity--part IYuping Ding, Peter F Landrum, Jing You, et al.
Ecology Letters|August 5, 2011
Combining α - and β -diversity models to fill gaps in our knowledge of biodiversityKarel Mokany, Thomas D Harwood, Jacob McC Overton, et al.
Biopharmaceutics & Drug Disposition|August 29, 2012
Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorptionM D Harwood, S Neuhoff, G L Carlson, et al.
Environmental Toxicology and Chemistry|July 13, 2012
Use of solid phase microextraction to estimate toxicity: relating fiber concentrations to body residues--part IIYuping Ding, Peter F Landrum, Jing You, et al.
Journal of Child Neurology|October 1, 1992
Magnetic resonance imaging evaluation of delayed myelination in Down syndrome: a case report and review of the literatureB K Koo, S Blaser, D Harwood-Nash, et al.
AJNR. American Journal of Neuroradiology|January 1, 1985
Radiologic characteristics of primitive neuroectodermal tumors in childrenN Altman, C R Fitz, S Chuang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2015
In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-Glycoprotein and Breast Cancer Resistance Protein: Part I: A Cross-Laboratory Comparison of Transporter-Protein Abundances and Relative Expression Factors in Human Intestine and Caco-2 CellsMatthew D Harwood, Brahim Achour, Sibylle Neuhoff, et al.
Pageof 17